loadpatents
name:-0.0033760070800781
name:-0.0025479793548584
name:-0.002493143081665
Caralli; Lisa Lynn Patent Filings

Caralli; Lisa Lynn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Caralli; Lisa Lynn.The latest application filed is for "pharmaceutical preparation for treating bone lesions caused by malignant neoplasms".

Company Profile
2.2.2
  • Caralli; Lisa Lynn - Del Mar CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Stable dosage form of etidronate-cytarabine conjugate, and use thereof
Grant 11,219,603 - Ivanova , et al. January 11, 2
2022-01-11
Pharmaceutical preparation treating bone lesions caused by malignant neoplasms
Grant 11,045,487 - Ivanova , et al. June 29, 2
2021-06-29
Pharmaceutical Preparation For Treating Bone Lesions Caused By Malignant Neoplasms
App 20190240245 - IVANOVA; Ekaterina Alekseevna ;   et al.
2019-08-08
Stable Dosage Form Of Etidronate-cytarabine Conjugate, And Use Thereof
App 20190038559 - IVANOVA; Ekaterina Alekseevna ;   et al.
2019-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed